Latest News


Researchers join celebrations for national award

Researchers join celebrations for national award

Kolling Institute researchers have been recognised with a prestigious award for an initiative to support people to return to work after injury. The project, named Early Matched Care at Australia Post, was named the 2021 Winner of Comcare’s national Recovery at and Return to Work Award. The research team was led by Professor Michael Nicholas, from the Pain Management Research Centre at RN.....
Read more

Category: Awards, Research Excellence

International knee transplant study to inform future care

International knee transplant study to inform future care

New funding announced by the Federal Government will see researchers from the Kolling Institute and the University of Sydney drive an international study to determine the best treatment for those with knee cartilage damage. More than $1 million dollars has been awarded through a collaborative research grant scheme involving Australia’s National Health and Medical Research Council and the.....
Read more

Category: Funding support, Musculoskeletal Research

Kolling researchers join global effort to reduce heart disease in women

Kolling researchers join global effort to reduce heart disease in women

Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioner.....
Read more

Category: Cardiovascular and Renal Research

Researchers to identify safer and more effective treatment pathways for rheumatoid and psoriatic arthritis

Researchers to identify safer and more effective treatment pathways for rheumatoid and psoriatic arthritis

Kolling researcher Professor Lyn March will lead a large, collaborative national trial to improve treatments and outcomes for those with disabling rheumatoid and psoriatic arthritis. Federal Government MRFF funding will see more than $2.7 million invested in the project which will involve 400 participants across the country. Professor March, who is also the head of the Department of Rheu.....
Read more

Category: Funding support, Musculoskeletal Research

Age and sex influence the adverse effects of multiple medications

Age and sex influence the adverse effects of multiple medications

There are calls for a carefully-considered, tailored approach to the prescription of multiple medicines with new research finding a person’s age and sex influence the impact of multiple medications. More than half of older Australians take five or more regular medications, with the higher number of medications directly linked to a higher chance of adverse reactions, like falls, confusion.....
Read more

Category: Neuroscience and Pain Research, New Treatment

Technology to bring relief to those with low back pain

Technology to bring relief to those with low back pain

With many of us looking to adopt a healthier lifestyle, researchers say a new approach may not only deliver benefits for your heart and waistline but may reduce low back pain as well. The condition affects one in six Australians or four million people and is the leading cause of adult musculoskeletal pain worldwide. Researchers from the University of Sydney and the Kolling Institute have.....
Read more

Category: Musculoskeletal Research, Research Excellence

High tech project offers hope for Parkinson’s treatment

High tech project offers hope for Parkinson’s treatment

Kolling researchers are set to lead a ground-breaking project to identify new drug therapies for those with Parkinson's disease. The project has been made possible following Federal Government funding through the National Drug Discovery Centre. Senior Kolling researcher Dr Daniel Whiten has welcomed the announcement, saying the funding will help our team translate our scientific progress.....
Read more

Category: Funding support

First large-scale trial of stem cell therapy for knee osteoarthritis launched

First large-scale trial of stem cell therapy for knee osteoarthritis launched

Kolling researcher Professor David Hunter will lead one of the world’s largest clinical trials into the effectiveness of stem cell therapy for those with knee osteoarthritis. More than 400 participants will be recruited for the SCUlpTOR study which will see trial sites established at Royal North Shore Hospital and the Menzies Institute in Hobart. Professor Hunter, the Florance and Cope .....
Read more

Category: Musculoskeletal Research, New Treatment

First Australian imaging technology to deliver research windfall

First Australian imaging technology to deliver research windfall

An exciting project between the University of Sydney and the Northern Sydney Local Health District will see a $15 million, revolutionary scanner installed at Royal North Shore Hospital, greatly improving patient care and research capabilities. Australia’s first Total Body Positron Emission Tomography (TB-PET) scanner will produce faster and higher quality whole-body PET/CT scans, with l.....
Read more

Category: World-leading technology

A simple mix of treatments holds the key to better hand function

A simple mix of treatments holds the key to better hand function

The base of our thumb may just be a small part of our hand, but osteoarthritis in that area can have a significant impact, making the simplest tasks difficult. The condition especially affects post-menopausal women, with figures indicating up to a third of women over 70 have this type of osteoarthritis. Increasing numbers of people are experiencing the condition, and yet current treatme.....
Read more

Category: Musculoskeletal Research, New Treatment